Part, Chapter, Paragraph
1 I, 2. 5 | generally means a shift in the sharing of risks between beneficiaries,
2 II, 4. 1 | of Healthy People 2010. Sharing of experiences with HLY
3 II, 5. 4. 6| the basis for knowledge sharing in Europe. The initiative
4 II, 5. 5. 3| will allow good practice sharing between the EU Member States.
5 II, 5. 14. 6| problem that requires the sharing of responsibilities among
6 II, 5. 15. 5| chance of success through the sharing of expertise and resources;
7 II, 6. 3. 1| action, in identifying and sharing best practice, and in suggesting
8 II, 9. 1 | greatly throughout Europe. Sharing knowledge about this diversity
9 II, 9. 3. 2| European countries can learn by sharing their experiences in healthcare
10 II, 9. 5. 4| practices in the interests of sharing information, future planning
11 III, 10. 4. 2| system which ensures the sharing of information concerning
12 III, 10. 4. 2| Feed (RASFF) to ensure the sharing of information concerning
13 III, 10. 4. 2| risk assessment of compound sharing the same mode of action
14 III, 10. 4. 2| channels and procedures for sharing information between the
15 IV, 11. 1. 3| largely by: a) increasing cost sharing; b) introducing competition
16 IV, 11. 1. 4| such as the degree of cost sharing in the system. In much of
17 IV, 11. 1. 4| countries that do rely on cost sharing arrangements, extensive
18 IV, 11. 1. 5| developing guidelines and sharing information, as in the EU
19 IV, 11. 5. 1| through international organ sharing.~ ~In the light of these
20 IV, 11. 5. 4| focused on promoting organ sharing and cooperation, seems to
21 IV, 11. 5. 6| promoting cooperation and sharing information and best practices
22 IV, 11. 5. 6| co-operation~ – Procurement and sharing of organs for highly immunised
23 IV, 11. 5. 7| cooperation among Member States, sharing programmes and best practices
24 IV, 11. 6 | coverage (including cost sharing), and how benefits are defined,
25 IV, 11. 6. 2| defining benefits, cost sharing. The implications of these
26 IV, 11. 6. 2| and depth (level of cost sharing) of coverage varies across
27 IV, 11. 6. 2| In some countries cost sharing has been introduced and
28 IV, 11. 6. 2| Careful design of cost sharing policies is needed to protect
29 IV, 11. 6. 2| European health systems), cost sharing for services in the public
30 IV, 11. 6. 2| payment include both cost sharing and direct payments) (see
31 IV, 11. 6. 2| can be used to reduce cost sharing or finance care for population
32 IV, 11. 6. 2| those eligible for cost sharing) (Thomson, Foubister and
33 IV, 11. 6. 2| private’ payments), cost sharing (individuals who are covered
34 IV, 11. 6. 2| the public system). Cost sharing exists to some extent in
35 IV, 11. 6. 2| three forms of direct cost sharing consist of: co-payment,
36 IV, 11. 6. 2| benefit to them. Hence, cost sharing is expected to improve efficiency
37 IV, 11. 6. 2| are under pressure, cost sharing has also been argued to
38 IV, 11. 6. 2| unlikely to result from a cost sharing arrangement. Finally, it
39 IV, 11. 6. 2| the literature shows cost sharing for prescription drugs leads
40 IV, 11. 6. 2| out-of-pocket payments into cost sharing, direct payments and, if
41 IV, 11. 6. 2| due to an increase in cost sharing but may also reflect increases
42 IV, 11. 6. 2| have in place some cost sharing for services covered by
43 IV, 11. 6. 2| In all countries, cost sharing is applied to pharmaceuticals
44 IV, 11. 6. 2| countries also require cost sharing for ambulatory physician
45 IV, 11. 6. 2| the point of use but cost sharing is applied to inpatient
46 IV, 11. 6. 2| For inpatient care, cost sharing tends to be in the form
47 IV, 11. 6. 2| Prescription drugs may have cost sharing in the form of a fixed co-payment
48 IV, 11. 6. 2| newer Member States, cost sharing for ambulatory physicians
49 IV, 11. 6. 2| introduced to limit cost sharing, e.g. in Estonia cost sharing
50 IV, 11. 6. 2| sharing, e.g. in Estonia cost sharing for primary care was abolished
51 IV, 11. 6. 2| European countries require cost sharing for at least some services,
52 IV, 11. 6. 2| in some countries, cost sharing arrangements were changed
53 IV, 11. 6. 2| 11.13. Examples for cost sharing exemptions~ ~ ~Clinical
54 IV, 11. 6. 4| solidarity principles by sharing risks across a larger population.
55 IV, 11. 6. 4| package and the level of cost sharing in the system; where services
56 IV, 11. 6. 5| literature review of cost sharing for prescription drugs:
57 IV, 11. 6. 5| 2004): An overview of cost sharing for health services in the
58 IV, 11. 6. 5| appropriate role for patient cost sharing. Critical challenges for
59 IV, 11. 6. 5| Mossialos E et al. (2003): Cost sharing for health services in the
60 IV, 12. 1 | order to facilitate data sharing –~ ~ ~Important aspects
61 IV, 12. 3 | problems they are increasingly sharing. Through the open method
62 IV, 12. 4 | by bringing together and sharing knowledge and information,
63 IV, 12. 10 | regulation to allow for the sharing of views with the Health
